Dr.reddy's Laboratories Ltd Metoprolol Export Data — India (DGFT 2022–2026)

Name: Dr.reddy's Laboratories Ltd Metoprolol Export Records India — #5 Exporter, 1,241 Shipments, $61.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Metoprolol

India Pharmaceutical Trade Intelligence

$811.1M306 Suppliers118 CountriesHS 30049074

ExportsIndia → UNITED STATES94.0%India → BRAZIL4.6%

ImportsSWEDEN → India$4565.7B UNITED STATES → India$1.3B

#1 Supplier: RUBICON RESEARCH #1 Buyer: CIPLA USA

Dr.reddy's Laboratories Ltd — Metoprolol Exporter #5 | $61.4M Trade Value | TransData Nexus | TransData Nexus

Dr.reddy's Laboratories Ltd — Metoprolol Exporter Profile

Indian Pharmaceutical Exporter · #5 for Metoprolol · $61.4M export value · DGFT Verified

Dr.reddy's Laboratories Ltd is the #5 Indian exporter of Metoprolol with $61.4M in export value and 1,241 verified shipments. Dr.reddy's Laboratories Ltd holds a 12.1% market share in Metoprolol exports across 7 countries.

Dr.reddy's Laboratories Ltd — Metoprolol Export Profile: Buyers & Destinations

Dr.reddy's Laboratories Ltd Metoprolol export treemap — buyers and destination countries | TransData Nexus

Where Does Dr.reddy's Laboratories Ltd Export Metoprolol?

Country	Value	Shipments	Share
UNITED STATES	$26.5M	789	57.2%
BRAZIL	$19.8M	602	42.7%
GERMANY	$24.8K	4	0.1%
NETHERLANDS	$22.5K	1	0.0%

Who Are the Top Buyers of Metoprolol from Dr.reddy's Laboratories Ltd?

Buyer	Country	Value	Orders
DR. REDDYS LABORATORIES, INC	UNITED STATES	$9.2M	221
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$4.4M	167
BANCO SANT ANDER BRASIL SA	BRAZIL	$4.3M	130
SANOFI MEDLEY FARMACEUTICA LTDA	BRAZIL	$3.8M	128
DR REDDYS LABORATORIES,INC	UNITED STATES	$3.5M	115
PRIORITY HEALTHCARE DISTRIBUTION	UNITED STATES	$2.2M	73
BIOLAB SANUS FARMACEUTICA LTDA	BRAZIL	$1.8M	73
BIOLAB SANUS FARMACEUTICA	BRAZIL	$1.7M	42
SANOFI MEDLEY FARMACEUTICA LTDA.,	BRAZIL	$1.7M	36
BIOLAB SANUS FARMACEUTICA LTD.A	BRAZIL	$1.6M	34

Dr.reddy's Laboratories Ltd supplies Metoprolol to 47 buyers globally. The largest buyer is DR. REDDYS LABORATORIES, INC (UNITED STATES), followed by NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) and BANCO SANT ANDER BRASIL SA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Metoprolol Formulations Does Dr.reddy's Laboratories Ltd Export?

Product Description / Formulation	Value	Shipments
METOPROLOL SUCCINATE EXTENDED-RELEASE TA	$9.9M	228
Succinato de metoprolol 50mg (30's Pack)	$999.9K	21
SUCCINATO DE METOPROLOL 25 MG (30S PACK)	$437.1K	11
300031539 SUCCINATO DEMETOPROLOL50 MG (3	$400.0K	8
300031539 SUCCINATO DE METOPROLOL 50 MG(COMPRIMIDOS REVESTIDOS DE LIBERACAO CONTROLADA)(49392X30'S)	$350.3K	13
Succinato de metoprolol 25mg (30's Pack)	$347.6K	11
300031538 SUCCINATO DE METOPROLOL 25 MG	$300.0K	6
300031539 (SUCCINATO DE METOPROLOL 50MG(	$300.0K	6
SUCCINATO DE METOPROLOL 25MG(30'S PACK)	$288.6K	9
SUCCINATO DE METOPROLOL 50MG	$250.0K	5

Dr.reddy's Laboratories Ltd exports 629 distinct Metoprolol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METOPROLOL SUCCINATE EXTENDED-RELEASE TA with 228 shipments worth $9.9M.

Regulatory Requirements: Exporting Metoprolol to Key Markets

What Dr.reddy's Laboratories Ltd must comply with to export Metoprolol to its top destination countries

United States — FDA

Approval Process

ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.

Timeline: 10–18 months for ANDA approval

GMP & Export Requirements

FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA

Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system

Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.

Brazil — ANVISA

Approval Process

Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.

Timeline: 12–24 months

GMP & Export Requirements

ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA

Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX

Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.

Germany — BfArM/EMA

Approval Process

Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.

Timeline: 12–18 months via Decentralized Procedure

GMP & Export Requirements

EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence

Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory

Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.

Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.

How Does Dr.reddy's Laboratories Ltd Compare to Nearest Metoprolol Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	DR.REDDY'S LABORATORIES LTD ★	$61.4M	1,241	7	$49.5K
1	RUBICON RESEARCH PRIVATE LIMITED	$26.6M	532	2	$50.0K
2	CIPLA LIMITED	$15.9M	319	1	$50.0K

Dr.reddy's Laboratories Ltd ranks #5 among 306 Indian Metoprolol exporters. Average shipment value of $49.5K compared to the market average of $651.6K. The closest competitors by value are RUBICON RESEARCH PRIVATE LIMITED and CIPLA LIMITED.

Which Indian Ports Ship Metoprolol Exports?

Port	Shipments	% Share
SAHAR AIR	1,639	16.2%
SAHAR AIR CARGO ACC (INBOM4)	1,096	10.8%
DELHI AIR CARGO ACC (INDEL4)	932	9.2%
HYDERABAD ICD	847	8.4%
DELHI AIR	673	6.7%
HYDERABAD ICD (INSNF6)	667	6.6%
NHAVA SHEVA SEA (INNSA1)	599	5.9%
Bombay Air	325	3.2%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Metoprolol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,405 individual customs records matching Dr.reddy's Laboratories Ltd exporting Metoprolol, covering 629 formulations to 7 countries via 47 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 118+ countries, 949+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Metoprolol

Metoprolol

Dr.reddy's Laboratories Ltd — Metoprolol Exporter Profile

Dr.reddy's Laboratories Ltd — Metoprolol Export Profile: Buyers & Destinations

Where Does Dr.reddy's Laboratories Ltd Export Metoprolol?

Who Are the Top Buyers of Metoprolol from Dr.reddy's Laboratories Ltd?

What Is India's Total Metoprolol Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?

What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Metoprolol Exports?

How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Metoprolol Exporters?

What Metoprolol Formulations Does Dr.reddy's Laboratories Ltd Export?

Regulatory Requirements: Exporting Metoprolol to Key Markets

United States — FDA

Brazil — ANVISA

Germany — BfArM/EMA

How Does Dr.reddy's Laboratories Ltd Compare to Nearest Metoprolol Exporters?

Which Indian Ports Ship Metoprolol Exports?

Metoprolol — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Metoprolol Export Data from Dr.reddy's Laboratories Ltd

Metoprolol Stats

Related Analysis

Need Detailed Export Data?

Data Source